Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

NGEN — NervGen Pharma Corp. Dilution Risk Tracker

Track NGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NGEN — Get alerts when the score changes →

As of October 13, 2026, NervGen Pharma Corp. (NGEN) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. NervGen Pharma Corp. has a market capitalization of $137.79M, 79.65M shares outstanding, 44 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NGEN.
🔔 Track NGEN — Get forecast alerts →

Market Data

Market Cap$137.79M
Shares Outstanding79.65M
Float68.03M
Cash$12.00M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding79.65MVerified float table or market cache
Public Float68.03MVerified float table or market cache
Market Cap$137.79MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

44 institutional holders · 1.68M shares
#1 PFG Investments, LLC 201.0K shares
#2 BANK OF AMERICA CORP /DE/ 200.7K shares
#3 MARSHALL WACE, LLP 200.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.83M
Days to Cover11.3
% of Float8.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

NGEN's DilutionScore has held steady at 35/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202635/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NGEN shares outstanding have increased 2.2% from 79.21M (Mar 2026) to 80.93M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 202680.93M68.03M▼ 1.27%
Apr 11, 202680.93M68.91M▲ 0.02%
Apr 10, 202680.93M68.90M▲ 0.06%
Apr 08, 202679.21M68.85M▲ 3.53%
Mar 23, 202679.21M66.51M▲ 0.23%
Mar 05, 202679.21M66.35M▲ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NGEN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NGEN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NGEN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NGEN
NGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.